Skip to main content
Livermore
Livermore
ZHEN

Morgan Stanley

SEC CIK
0000895421
Latest filing
Aug 13, 2026

VVOS holding history

Vivos Therapeutics, Inc. in every 13F filed by Morgan Stanley, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

VVOS overviewAll 13F holders of VVOSFull Q2 2026 holdings

Shares (Q2 2026)
7
Value
$3
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of VVOS by Morgan Stanley, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20267$3<0.1%00.0%UnchangedHolders
Q1 20267$8<0.1%00.0%UnchangedHolders
Q4 20257$14<0.1%−1,058−99.3%ReducedHolders
Q3 20251,065$3.30K<0.1%00.0%UnchangedHolders
Q2 20251,065$3.37K<0.1%−249−18.9%ReducedHolders
Q1 20251,314$3.75K<0.1%+1,240+1,675.7%AddedHolders
Q4 202474$317<0.1%00.0%UnchangedHolders
Q3 202474$193<0.1%+6+8.8%AddedHolders
Q2 202468$151<0.1%+1+1.5%AddedHolders
Q1 202467$324<0.1%00.0%UnchangedHolders
Q4 202367$833<0.1%00.0%UnchangedConverted for a 1-for-25 splitHolders
Q3 20231,667$320<0.1%00.0%UnchangedHolders
Q2 20231,667$850<0.1%+267+19.1%AddedHolders
Q1 20231,400$478<0.1%00.0%UnchangedHolders
Q4 20221,400$563<0.1%−1−0.1%ReducedHolders
Q3 20221,401$1.00K<0.1%−999−41.6%ReducedHolders
Q2 20222,400$3.00K<0.1%−1,221−33.7%ReducedHolders
Q1 20223,621$9.00K<0.1%+1,220+50.8%AddedHolders
Q4 20212,401$5.00K<0.1%−129−5.1%ReducedHolders
Q3 20212,530$10.0K<0.1%+1,055+71.5%AddedHolders
Q2 20211,475$7.00K<0.1%+975+195.0%AddedHolders
Q1 2021500$3.00K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.